1. Araujo SF, Jardim LC, Ferrazzo KL, Skupien JA, Antoniazzi RP. Association between tamoxifen and tooth loss in women with breast cancer. Support Care Cancer. 2022;30:8193-9.

https://doi.org/10.1007/s00520-022-07271-4

PMid:35796887 

2. Elani HW, Batista AFM, Thomson WM, Kawachi I, Chiavegatto Filho ADP. Predictors of tooth loss: A machine learning approach. PLoS One. 2021;16:e0252873.

https://doi.org/10.1371/journal.pone.0252873

PMid:34143814 PMCid:PMC8213149

3. Mark AM. Preventing tooth loss. J Am Dent Assoc. 2020;151:712.

https://doi.org/10.1016/j.adaj.2020.06.021

PMid:32854872 

4. Pitchika V, Jordan RA, Norderyd O, Rolander B, Welk A, Völzke H, et al. Factors influencing tooth loss in European populations. J Clin Periodontol. 2022;49:642-53.

https://doi.org/10.1111/jcpe.13642

PMid:35569026 

5. Hag MS, Sabbah W. Is tooth loss associated with multiple chronic conditions?. Acta Odontol Scand. 2023;81:443-8.

PMid:36634031 

6. Yin W, Wang J, Jiang L, James KY. Cancer and stem cells. Exp Biol Med (Maywood). 2021;246:1791-1801.

https://doi.org/10.1177/15353702211005390

PMid:33820469 PMCid:PMC8381702

7. Diori KI, Sanlier SH. Reviewing cancer's biology: an eclectic approach. J Egypt Natl Canc Inst. 2021;33:32.

https://doi.org/10.1186/s43046-021-00088-y

PMid:34719756 

8. Youn HJ, Han W. A Review of the epidemiology of breast cancer in Asia: Focus on Risk Factors. Asian Pac J Cancer Prev. 2020;21:867-80.

https://doi.org/10.31557/APJCP.2020.21.4.867

PMid:32334446 PMCid:PMC7445974

9. Łukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanisławek A. Breast Cancer-Epidemiology, risk factors, classification, prognostic markers, and current treatment Strategies-An Updated Review. Cancers (Basel). 2021;13:4287.

https://doi.org/10.3390/cancers13174287

PMid:34503097 PMCid:PMC8428369

10. Ustaoğlu G, Göller Bulut D, Üyetürk Ü, Uysal Ö. Evaluation of periodontal health in breast cancer patients undergoing tamoxifen or aromatase inhibitors drugs therapy: A cross-sectional study. Spec Care Dentist. 2021;41:41-8.

https://doi.org/10.1111/scd.12538

PMid:33156573 

11. Gadaleta E, Thorn GJ, Ross-Adams H, Jones LJ, Chelala C. Field cancerization in breast cancer. J Pathol. 2022;257:561-74.

https://doi.org/10.1002/path.5902

PMid:35362092 PMCid:PMC9322418

12. Ferrillo M, Migliario M, Marotta N, Lippi L, Antonelli A, Calafiore D, et al. Oral health in breast cancer women with vitamin D deficiency: A Machine Learning Study. J Clin Med. 2022;11:4662.

https://doi.org/10.3390/jcm11164662

PMid:36012901 PMCid:PMC9410090

13. Jardim LC, Flores PT, do Carmo Dos Santos Araújo M, Chiesa J, de Moraes CMB, Antoniazzi RP. Oral health-related quality of life in breast cancer survivors. Support Care Cancer. 2020;28:65-71.

https://doi.org/10.1007/s00520-019-04792-3

PMid:30982094 

14. Zhang Y, Ren X, Hu T, Cheng R, Bhowmick NA. The relationship between periodontal disease and breast cancer: from basic mechanism to clinical management and prevention. Oral health prev dent. 2023;21:49-60.

PMID: 36794777

15. Wang T, Zhou Y, Cao G. Pharmacogenetics of tamoxifen therapy in Asian populations: from genetic polymorphism to clinical outcomes. Eur J Clin Pharmacol. 2021;77:1095-111.

https://doi.org/10.1007/s00228-021-03088-y

PMid:33515076 

16. Ortiz J, Aranda FJ, Teruel JA, Ortiz A. Dissimilar action of tamoxifen and 4-hydroxytamoxifen on phosphatidylcholine model membranes. Biophys Chem. 2021;278:106681.

https://doi.org/10.1016/j.bpc.2021.106681

PMid:34530285 

17. Thorneloe RJ, Hall LH, Walter FM, Side L, Lloyd KE, Smith SG. Knowledge of potential harms and benefits of tamoxifen among women considering breast cancer preventive therapy. Cancer Prev Res (Phila). 2020;13:411-22.

https://doi.org/10.1158/1940-6207.CAPR-19-0424

PMid:31988145 PMCid:PMC7611305

18. Hosainzadegan H, Parvan R, Hosainzadegan M. A retrospective study comparing oral health in cancer patients and healthy people. European journal of translational myology. 2022;32:10672.

https://doi.org/10.4081/ejtm.2022.10672

PMid:36039833 PMCid:PMC9830400

19. Ali AH,Al-Janabi. Repurposing of tamoxifen against the oral bacteria. Turkish journal pharmaceutical Sci. 2021;18:68-74.

https://doi.org/10.4274/tjps.galenos.2019.23500

PMid:33634670 PMCid:PMC7957305

20. Lucisano MP, da Silva RAB, de Sousa Pereira AP, Romualdo PC, Feres M, de Queiroz AM, et al. Alteration of the oral microbiota may be a responsible factor, along with estrogen deficiency, by the development of larger periapical lesions. Clin Oral Investig. 2021;25:3651-62.

https://doi.org/10.1007/s00784-020-03688-5

PMid:33188615 

21. Su X, Jin K, Zhou X, Zhang Z, Zhang C, Li Y, et al. The association between sex hormones and periodontitis among American adults: A cross-sectional study. Front Endocrinol (Lausanne). 2023;14:1125819.

https://doi.org/10.3389/fendo.2023.1125819

PMid:36864844 PMCid:PMC9971556

22. Shah R, Shah H, Thakkar K, Parikh N. Conventional therapies of oral cancers: highlights on chemotherapeutic agents and radiotherapy, their adverse effects, and the cost burden of conventional therapies. Crit Rev Oncog. 2023;28:1-10.

https://doi.org/10.1615/CritRevOncog.2023046835

PMid:37830213